A business in context

PAVM research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-22 · 8029 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 8-K · Current report

    Report date 2026-09-09 · 0001493152-26-042021 · Items 1.01,9.01

  2. 8-K · Current report

    Report date 2026-08-14 · 0001493152-26-038072 · Items 2.02,7.01,9.01

  3. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001437749-26-027733

  4. 8-K · Current report

    Report date 2026-06-24 · 0001493152-26-029944 · Items 5.02,5.07,9.01

  5. 8-K · Current report

    Report date 2026-05-15 · 0001493152-26-023352 · Items 2.02,7.01,9.01

  6. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001437749-26-017121

  7. DEF 14A · Proxy statement

    Report date 2026-04-30 · 0001493152-26-020705

  8. 4 · Ownership change

    Report date 2026-04-02 · 0001094891-26-000191

  9. 4 · Ownership change

    Report date 2026-04-02 · 0001094891-26-000165

  10. 4 · Ownership change

    Report date 2026-04-02 · 0001094891-26-000157

  11. 4 · Ownership change

    Report date 2026-04-02 · 0001094891-26-000155

  12. 4 · Ownership change

    Report date 2026-04-02 · 0001094891-26-000153

  13. 4 · Ownership change

    Report date 2026-04-02 · 0001094891-26-000151

  14. 4 · Ownership change

    Report date 2026-04-02 · 0001094891-26-000149

  15. 4 · Ownership change

    Report date 2026-04-02 · 0001094891-26-000147

  16. 8-K · Current report

    Report date 2026-03-30 · 0001493152-26-013477 · Items 2.02,7.01,9.01

  17. 8-K · Current report

    Report date 2026-03-27 · 0001493152-26-013264 · Items 5.02,5.03,5.07,9.01

  18. 10-K · Annual report

    Report date 2025-12-31 · 0001437749-26-010115

  19. DEF 14A · Proxy statement

    Report date 2026-02-24 · 0001493152-26-007884

  20. 8-K · Current report

    Report date 2026-02-03 · 0001493152-26-005023 · Items 1.01,1.02,2.03,3.02,3.03,5.03,7.01,9.01

  21. 8-K · Current report

    Report date 2026-01-21 · 0001493152-26-003409 · Items 8.01,9.01

  22. 8-K · Current report

    Report date 2025-12-30 · 0001493152-25-029510 · Items 3.03,5.03,7.01,9.01

  23. 8-K · Current report

    Report date 2025-12-05 · 0001493152-25-026368 · Items 5.07,9.01

  24. 8-K · Current report

    Report date 2025-11-13 · 0001493152-25-022122 · Items 2.02,7.01,9.01

  25. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001493152-25-022017

  26. DEF 14A · Proxy statement

    Report date 2025-10-31 · 0001493152-25-020379

  27. 8-K · Current report

    Report date 2025-09-11 · 0001493152-25-013048 · Items 8.01,9.01

  28. 8-K · Current report

    Report date 2025-08-14 · 0001641172-25-023729 · Items 2.02,7.01,9.01

  29. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001493152-25-011923

  30. 8-K · Current report

    Report date 2025-07-29 · 0001493152-25-011491 · Items 8.01,9.01

  31. 8-K · Current report

    Report date 2025-06-23 · 0001641172-25-016227 · Items 1.01,9.01

  32. 8-K · Current report

    Report date 2025-06-18 · 0001641172-25-015612 · Items 5.02,5.07,9.01

  33. 8-K · Current report

    Report date 2025-05-15 · 0001641172-25-010536 · Items 2.02,7.01,9.01

  34. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001641172-25-010433

  35. DEF 14A · Proxy statement

    Report date 2025-04-30 · 0001641172-25-007773

  36. 8-K · Current report

    Report date 2025-04-23 · 0001641172-25-006250 · Items 4.01,9.01

  37. 8-K · Current report

    Report date 2025-04-17 · 0001641172-25-005279 · Items 1.01,9.01

  38. 8-K · Current report

    Report date 2025-04-11 · 0001641172-25-003741 · Items 8.01,9.01

  39. 8-K · Current report

    Report date 2025-03-25 · 0001641172-25-000517 · Items 2.02,7.01,9.01

  40. 10-K · Annual report

    Report date 2024-12-31 · 0001641172-25-000364

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-15 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 0 transaction rows0SGrant / award: 0 transaction rows0AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

0 matching transaction rows.

No matching transaction rows in the covered quarter. This does not establish that no insider transactions occurred.

Identity & relationships

Wikidata structured data · retrieved 2026-10-15 · 1663 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001624326PAVmed Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-15 · 1199 checked identities; 0 unavailable records

Search names and former names
  • PAXmed Inc. · former SEC name · 2014-11-19 to 2015-03-26

Revenue in constant purchasing power

USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$3.00M$3.22M
2023-12-31$2.45M$2.71M
2022-12-31$377.0K$434.0K
2021-12-31$500.0K$621.6K

Bureau of Labor Statistics · retrieved 2026-10-22 · 9 selected series; gaps remain missing

Explore the CPI history ↗